TABLE 1.
Clinical characteristics |
Patients with baseline serum and healthy control(%) (N = 24) |
---|---|
Demographic characteristics | |
Age > 50 years | 33.3 |
Male | 58.4 |
POEMS syndrome‐related characteristics | |
Polyneuropathy (ONLS > 4) | 20.8 |
Organomegaly | |
Hepatomegaly | 33.3 |
Splenomegaly | 54.2 |
Lymphadenopathy | |
Endocrinopathy | 29.2 |
Diabetes | 8.3 |
Hypothyroidism | 75.0 |
Monoclonal gammopathy | |
IgA type heavy chain | 54.2 |
SPE > 5 g/L | 12.4 |
BMPC > 10% | 0.0 |
Skin lesions | |
Pigmentation | 91.6 |
Angioma | 58.3 |
Extravascular volume overload | |
Peripheral oedema | 75.0 |
Ascites | 41.7 |
Pleural effusion | 37.5 |
Castleman disease |
66.7 (N = 3) a |
Papilloedema |
12.5 (N = 16) b |
Osteosclerosis | 37.5 |
Polycythemia | 16.7 |
Thrombocytosis | 20.8 |
Hypoalbuminemia (Alb < 30g/L) | 8.3 |
Renal dysfunctione GFR < 30 ml/min/ 1.73m2 | 4.2 |
24h urinary protein > 1g | 4.2 |
Risk stratification | |
Low risk | 54.2 |
Medium risk | 33.3 |
High risk | 12.5 |
Initial treatment | |
ASCT | 20.8 |
MDex | 4.2 |
LDex | 25 |
BDex | 50 |
A total of 3 out of 24 patients underwent lymph node biopsy and 2 patients were with Castleman disease.
A total of 16 out of 24 patients underwent ophthalmoscope examination and 2 patients were with papilloedema.